
- Volume 0 0
Mallinckrodt Teams with Zydus
Mallinckrodt Pharmaceuticals Genericshas entered into a strategicalliance with Zydus Cadila's US subsidiary,Zydus Pharmaceuticals Inc.The agreement calls for MallinckrodtPharmaceuticals Generics to marketand sell products under a sharedMallinckrodt-Zypharma label. Theproducts will be developed and registeredby Zydus Pharmaceuticals andwill be manufactured by Zydus Cadilaat its US FDA-approved manufacturingplant in Ahmedabad, India.
By melding Mallinckrodt's marketingand distribution networks withZydus Cadila's product developmentand manufacturing success, Mallinckrodtexpands its product portfolio andpipeline.
Articles in this issue
over 20 years ago
Internet Prescribing 2005over 20 years ago
COMPOUNDING HOTLINEover 20 years ago
Breakfast Cereals Take a Step in the Right Directionover 20 years ago
Refined Carbs Cause Obesityover 20 years ago
Obesity Problematic for Young Transplant Patientsover 20 years ago
High BMI Linked to Dementiaover 20 years ago
When Does Compounding Become Manufacturing?over 20 years ago
Talking to Your Diabetes Patients About Fiberover 20 years ago
Counseling Guide for Avoiding Asthma Triggersover 20 years ago
RA Drug Does Not Alter Cholesterol RatioNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.